Two pharmaceuticals developed to prevent blood clots that lead to heart attacks and strokes have caused extremely dangerous side effects for some users. Plavix and Pradaxa, both initially approved by the FDA, can cause internal bleeding and other gastrointestinal problems. If either drug has affected you or someone you care about in this way, Morris Bart is on the case.


Plavix, which the FDA approved in 1997, comes with serious health risks including bleeding ulcers, thrombotic thrombocytopenic purpura (TTP) and uncontrollable to gastrointestinal bleeding. The Morris Bart personal injury attorneys are helping clients suffering from these side effects by obtaining two types of medical records: proof the patient was taking Plavix and that Plavix was being taken at the time they were hospitalized for a bleeding incident. Bleeding induced hospitalization from Plavix must be proved to file a lawsuit against the manufacturer.

A study in The New England Journal of Medicine (April, 2006) showed that patients taking Plavix were 12 times more likely than those taking aspirin to suffer severe gastrointestinal bleeding and chronic ulcers. Also, research revealed that Plavix and aspirin combined offered patients no benefit over low does aspirin therapy.

On March 12, 2012, the FDA issued a œblack box warning for Plavix in order to warn about the reduced effectiveness in patients who are poor metabolizers of Plavix.

On February, 21, 2012, the Cardiovascular and Cerebrovascular Disease Journal published a study showing that aspirin can be as effective as Plavix in improving leg circulation for patients with peripheral artery disease.


Pradaxa is very similar to Plavix, intended to prevent blood clots in patients with atrial fibrillation. The FDA approved Pradaxa in October 2010 with the understanding that it was supposedly safer than traditional blood thinners such as Warfarin.  Excessive bleeding from Warfarin can be stopped with the use of Vitamin K, however there is no antidote for bleeding from Pradaxa. Patients prescribed Pradaxa became the subject of investigation in New Zealand in September 2011 when five elderly patients died and 36 other patients suffered from internal bleeding.

According to a new report on June 7, 2012, from the Institute of Safe Medicine Practices, the U.S. Food and Drug Administration received 3,781 adverse event reports associated with Pradaxa in 2010, more than were associated with any other drug the agency monitors.

These alarming developments concerning the Plavix and Pradaxa blood thinners have all led to lawsuits for patients seeking retribution.

If you have experienced any of these side effects related to Plavix or Pradaxa, contact the Morris Bart personal injury law firm to handle your personal injury case.

July 31, 2012 | Categories: Class Action |